Nixon Peabody
Pac Premier
You are here:  Home  >  Biotech  >  Current Article

Nuevolution shareholders OK takeover by Amgen

By   /   Monday, July 8th, 2019  /   Comments Off on Nuevolution shareholders OK takeover by Amgen

    Print       Email
Shareholders of Copenhagen-based research institute Nuevolution accepted a $167 million takeover bid from Amgen, the Thousand Oaks biotech heavyweight announced June 8. Amgen made the offer May 22, valuing the stock at around $3.37 per share, more than twice its May 21 closing price on the Nasdaq Stockholm exchange. Additionally, Amgen agreed to purchase another…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Trade Desk stock takes sharp dive after earnings report

Read More →